{"id":"https://openalex.org/W3095366200","doi":"https://doi.org/10.1182/blood-2020-142620","title":"Treating MRD Positivity in Multiple Myeloma: An Allogeneic GM-CSF-Based Vaccine in Combination with Lenalidomide Induces Long-Term Remissions in Patients with Low Disease Burden","display_name":"Treating MRD Positivity in Multiple Myeloma: An Allogeneic GM-CSF-Based Vaccine in Combination with Lenalidomide Induces Long-Term Remissions in Patients with Low Disease Burden","publication_year":2020,"publication_date":"2020-11-05","ids":{"openalex":"https://openalex.org/W3095366200","doi":"https://doi.org/10.1182/blood-2020-142620","mag":"3095366200"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-142620","doi":"https://doi.org/10.1182/blood-2020-142620","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-142620","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005922052","display_name":"Luca Biavati","orcid":"https://orcid.org/0000-0001-7870-5754","observed_orcids":["https://orcid.org/0000-0001-7870-5754"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luca Biavati","raw_affiliation_strings":["Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089094849","display_name":"Carol Ann Huff","orcid":"https://orcid.org/0000-0003-0545-0708","observed_orcids":["https://orcid.org/0000-0003-0545-0708"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol Ann Huff","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104074122","display_name":"Anna K. Ferguson","orcid":"https://orcid.org/0000-0003-2739-8445","observed_orcids":["https://orcid.org/0000-0003-2739-8445"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Ferguson","raw_affiliation_strings":["Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111939286","display_name":"Lakshmi Rudraraju","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lakshmi Rudraraju","raw_affiliation_strings":["Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041973617","display_name":"Cristina Zucchinetti","orcid":"https://orcid.org/0000-0002-8529-6490","observed_orcids":["https://orcid.org/0000-0002-8529-6490"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cristina Zucchinetti","raw_affiliation_strings":["Johns Hopkins University, Baltimore,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University, Baltimore,","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010064754","display_name":"Rachel Gittelman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106996","display_name":"Adaptive Biotechnologies (United States)","ror":"https://ror.org/01gbt6a54","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel Gittelman","raw_affiliation_strings":["Adaptive Biotech, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adaptive Biotech, Seattle, WA","institution_ids":["https://openalex.org/I4210106996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018788244","display_name":"Sarah Johnson","orcid":"https://orcid.org/0000-0003-3034-0666","observed_orcids":["https://orcid.org/0000-0003-3034-0666"]},"institutions":[{"id":"https://openalex.org/I4210106996","display_name":"Adaptive Biotechnologies (United States)","ror":"https://ror.org/01gbt6a54","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Johnson","raw_affiliation_strings":["Adaptive Biotech, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adaptive Biotech, Seattle, WA","institution_ids":["https://openalex.org/I4210106996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089581942","display_name":"Catherine Miller Sanders","orcid":"https://orcid.org/0000-0001-5058-0486","observed_orcids":["https://orcid.org/0000-0001-5058-0486"]},"institutions":[{"id":"https://openalex.org/I4210106996","display_name":"Adaptive Biotechnologies (United States)","ror":"https://ror.org/01gbt6a54","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Sanders","raw_affiliation_strings":["Adaptive Biotech, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adaptive Biotech, Seattle, WA","institution_ids":["https://openalex.org/I4210106996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026962210","display_name":"Abbas Abbas Ali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210150714","display_name":"Johns Hopkins Hospital","ror":"https://ror.org/05cb1k848","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210150714"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abbas Abbas Ali","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, John's Hopkins Hospital, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, John's Hopkins Hospital, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210150714","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011002242","display_name":"Kimberly Ann Noonan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly Noonan","raw_affiliation_strings":["Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034547254","display_name":"Ivan Borrello","orcid":"https://orcid.org/0000-0002-7316-8862","observed_orcids":["https://orcid.org/0000-0002-7316-8862"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ivan M. Borrello","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"136","issue":"Supplement 1","first_page":"8","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9779999852180481},{"id":"https://openalex.org/keywords/allogeneic-vaccine","display_name":"allogeneic vaccine","score":0.8209999799728394},{"id":"https://openalex.org/keywords/gm-csf","display_name":"GM-CSF","score":0.9049999713897705},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9190000295639038},{"id":"https://openalex.org/keywords/gvax","display_name":"GVAX","score":0.8560000061988831},{"id":"https://openalex.org/keywords/near-complete-response","display_name":"near complete response","score":0.7210000157356262},{"id":"https://openalex.org/keywords/tcr-repertoire","display_name":"T cell receptor repertoire","score":0.7080000042915344},{"id":"https://openalex.org/keywords/b-cell-receptor-sequencing","display_name":"B cell receptor sequencing","score":0.609000027179718},{"id":"https://openalex.org/keywords/mrd-quantification","display_name":"MRD quantification","score":0.621999979019165},{"id":"https://openalex.org/keywords/long-term-remission","display_name":"long-term remission","score":0.6919999718666077},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.5350000262260437},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.3100000023841858},{"id":"https://openalex.org/keywords/u266","display_name":"U266","score":0.5289999842643738},{"id":"https://openalex.org/keywords/k562-cells","display_name":"K562 cells","score":0.9940000176429749}],"concepts":[{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.7758780717849731},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7478517889976501},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6396331787109375},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.6189466714859009},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5526028871536255},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4851556420326233},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4810119569301605},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.47482284903526306},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.451377272605896},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.3804572522640228}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-142620","doi":"https://doi.org/10.1182/blood-2020-142620","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-142620","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.7599999904632568,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2985308823","https://openalex.org/W3206400126","https://openalex.org/W323908695","https://openalex.org/W2591039649","https://openalex.org/W2921147826","https://openalex.org/W2904141226","https://openalex.org/W4404624528","https://openalex.org/W2538623426","https://openalex.org/W7093122532","https://openalex.org/W3097940646"],"abstract_inverted_index":{"Introduction:":[0],"Novel":[1],"therapies":[2],"have":[3],"increased":[4,442,532],"the":[5,49,60,231,249,281,312,326,342,345,347,382,540,582,624,635,649],"complete":[6],"response":[7,187,664],"(CR)":[8],"rates":[9],"in":[10,17,25,72,77,81,145,156,491,506,569,602,621,634,657,677],"multiple":[11],"myeloma":[12],"(MM)":[13],"with":[14,40,74,79,147,395,441,473,493,604],"corresponding":[15],"improvement":[16],"progression":[18],"free":[19],"survival":[20],"(PFS).":[21],"However,":[22],"relapse":[23,399,446,564],"occurs":[24],"a":[26,63,91,111,130,294,300,318,465,554,573,618,627],"significant":[27],"number":[28],"of":[29,51,62,117,168,173,191,260,280,290,303,321,344,374,385,403,444,459,497,511,550,584,626,637,686],"patients.":[30,369],"Emerging":[31],"evidence":[32],"strongly":[33],"correlates":[34],"minimal":[35],"residual":[36],"disease":[37,163,175,339,371,563,590,642,663],"(MRD)":[38],"negativity":[39,544,616],"improved":[41,546],"clinical":[42,46,383,445,547],"outcome.":[43],"Nonetheless,":[44],"definitive":[45],"guidance":[47],"on":[48,110,367,682],"management":[50],"MRD-positive":[52],"MM":[53,80,122,273,475,600,639,656],"is":[54,617,631,648],"currently":[55],"lacking.":[56],"Here":[57],"we":[58],"present":[59],"results":[61],"phase":[64],"II":[65],"trial":[66,170,282],"evaluating":[67],"an":[68,585,598,658,683],"allogeneic":[69,599],"GM-CSF":[70,131],"vaccine":[71,115,601],"combination":[73,146,603],"lenalidomide":[75],"(Len)":[76],"patients":[78,89,158,274,291,336,394,420,492,513,551],"near":[82,93],"CR":[83,94,296],"(NCT01349569).":[84],"Methods:":[85],"To":[86,644],"be":[87,331],"enrolled,":[88],"required":[90,566],"sustained":[92],"(defined":[95],"as":[96,285,333,665,667],"no":[97],"measurable":[98],"M-spike":[99,556],"and":[100,126,176,188,193,201,211,230,251,263,387,482,487,509,514,528,533,545,610],"positive":[101],"immunofixation,":[102],"IFE)":[103,298],"for":[104,150,213,255,315,417,516,562,581],"at":[105,151,208,299],"least":[106,152],"four":[107,140],"months":[108,144,305],"while":[109,414],"Len-containing":[112],"regimen.":[113],"The":[114,165,180,216,241,277,370],"consisted":[116],"two":[118],"allogeneic,":[119],"commercially":[120],"available":[121],"cell":[123,134,196,227,524,577],"lines":[124],"(U266":[125],"H929)":[127],"coupled":[128],"to":[129,178,186,224,236,247,293,311,380,518,640,653,660],"producing":[132],"leukemia":[133],"line":[135],"(K562,":[136],"GVAX\u00ae).":[137],"Patients":[138],"received":[139],"vaccinations":[141],"over":[142],"6":[143,335],"Len":[148,159,605],"maintenance":[149],"1":[153,401],"year,":[154],"although":[155],"most":[157],"was":[160,222,234,244,283,350,365,377,421,439,471,488],"continued":[161],"until":[162],"progression.":[164,643],"primary":[166,278],"endpoints":[167,182],"this":[169,647],"were":[171,183,206,266,275,531],"eradication":[172],"detectable":[174,555],"conversion":[177],"CR.":[179],"secondary":[181],"safety,":[184],"time":[185,302,343],"immune":[189,264,586,629],"monitoring":[190,265],"vaccine-":[192],"MM-specific":[194],"T":[195,226,261,462,485,523,576],"responses.":[197],"Bone":[198],"marrow":[199],"(BM)":[200],"peripheral":[202],"blood":[203],"(PB)":[204],"samples":[205],"collected":[207],"pre-established":[209],"timepoints":[210],"cryopreserved":[212],"subsequent":[214],"analyses.":[215],"ImmunoSEQ\u00ae":[217,242],"assay":[218,243],"(AdaptiveBiotechnologies,":[219],"Seattle,":[220],"WA)":[221],"used":[223,235,246,379],"sequence":[225,248],"receptors":[228,254],"(TCR)":[229],"resulting":[232],"data":[233,595],"analyze":[237],"TCR":[238],"repertoire":[239],"metrics.":[240],"also":[245],"IGH":[250],"IGK/L":[252],"B-cell":[253],"MRD":[256,363,389,397,419,438,543,615],"quatification.":[257],"Deep":[258],"phenotyping":[259,458],"cells":[262,376,463,486],"performed":[267,366],"by":[268],"flow":[269],"cytometry.":[270],"Results:":[271],"Fifteen":[272],"enrolled.":[276],"enpoint":[279],"met":[284],"53%":[286],"(n":[287],"=":[288,307,360,406,425,434,450],"8/15)":[289],"converted":[292],"true":[295],"(negative":[297],"median":[301,319,327,348,415],"11.6":[304],"(p":[306],"0.011":[308],"when":[309],"compared":[310],"25%":[313],"threshold":[314,373],"futility).":[316],"With":[317],"follow-up":[320],"5.13":[322],"years":[323,352,536],"from":[324,353],"enrollment,":[325],"PFS":[328,416],"could":[329],"not":[330,559],"estimated":[332],"only":[334],"(40%)":[337],"experienced":[338,398],"relapse.":[340,669],"At":[341],"analysis,":[346],"OS":[349],"7.8":[351],"enrollment":[354],"(95%":[355],"CI:":[356,453],"4.2-7.8":[357],"years,":[358],"n":[359],"6/15,":[361],"40%).":[362],"testing":[364],"7":[368,535],"burden":[372],"105/106":[375],"arbitrarily":[378],"evaluate":[381],"significance":[384],"high-level":[386,396,437,494],"low-level":[388,418],"positivity.":[390],"Interestingly,":[391],"all":[392,512],"3":[393],"within":[400],"year":[402],"vaccination":[404],"(median":[405,424],"4.8":[407],"months,":[408,427,432],"range:":[409,428],"2.8":[410],"-":[411,430,455],"9.5":[412],"months),":[413],"significantly":[422],"prolonged":[423,474],"84.15":[426],"51.9":[429],"97.3":[431],"p":[433],"0.01).":[435],"Consistently,":[436],"associated":[440,472],"likelihood":[443],"(hazard":[447],"ratio,":[448],"HR":[449],"25.79,":[451],"95%":[452],"2.17":[454],"306.4).":[456],"Immune":[457],"BM":[460,508],"CD8+":[461,484],"identified":[464,500,572],"CD27-":[466],"DNAM1-/low":[467],"subpopulation":[468],"whose":[469],"abundance":[470],"remission.":[476],"This":[477],"subset":[478],"included":[479],"senescent,":[480],"effector":[481],"exhausted":[483],"nearly":[489],"absent":[490],"MRD.":[495],"Analysis":[496],"T-cell":[498,502],"repertoires":[499],"vaccine-specific":[501,527],"clonotypes":[503],"that":[504,557,597],"expanded":[505],"both":[507],"PB":[510],"persisted":[515,534],"up":[517],"seven":[519],"years.":[520],"Accordingly,":[521],"polyfunctional":[522],"responses":[525],"against":[526],"MM-related":[529],"antigens":[530],"after":[537],"enrollment.":[538],"Despite":[539],"correlation":[541],"between":[542],"outcome,":[548],"47%":[549],"subsequently":[552],"developed":[553],"did":[558],"meet":[560],"criteria":[561],"nor":[565],"any":[567],"change":[568],"treatment.":[570],"We":[571],"bone":[574],"marrow-resident":[575],"population":[578],"likely":[579,632],"responsible":[580],"establishment":[583,625],"equilibrium":[587,630],"mediating":[588],"long-term":[589,612],"control.":[591],"Conclusions:":[592],"Collectively,":[593],"these":[594],"demonstrate":[596],"effectively":[606],"stimulates":[607],"antitumor":[608],"immunity":[609],"supports":[611],"remissions.":[613],"Although":[614],"critical":[619],"factor":[620],"maintaining":[622],"remission,":[623],"MM-MGUS":[628],"crucial":[633],"setting":[636],"MRD+":[638,655],"prevent":[641,668],"our":[645],"knowledge,":[646],"first":[650],"study":[651],"attempting":[652],"treat":[654],"effort":[659],"further":[661],"improve":[662],"well":[666],"Disclosures":[670],"Sanders:":[671],"Adaptive":[672],"Biotechnologies:":[673],"Current":[674],"equity":[675],"holder":[676],"private":[678],"company.":[679],"Ali:Celgene:":[680],"Membership":[681],"entity's":[684],"Board":[685],"Directors":[687],"or":[688],"advisory":[689],"committees.":[690],"Noonan:Aduro:":[691],"Patents":[692,703],"&":[693,704],"Royalties.":[694],"Borrello:WindMIL":[695],"Therapeutics:":[696],"Other:":[697],"Founder":[698],",":[699],"Research":[700,707],"Funding;":[701],"Aduro:":[702],"Royalties;":[705],"Celgene:":[706],"Funding.":[708]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-11-09T00:00:00"}